CSI Market
Sign In | Register

Aurinia Pharmaceuticals Inc (AUPH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AUPH Annual Balance Sheets →
The data below summarizes Aurinia Pharmaceuticals Inc's balance sheet position from Sep 30 2025 to Sep 30 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/AUPH/balance-sheets
https://api.csimarket.com/api/v1/companies/AUPH/fundamentals
https://api.csimarket.com/api/v1/companies/AUPH/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent45.79
Cash & Short-term Investments45.00
Accounts receivable47.41
Other Receivables1.20
Inventories43.73
Other Current Assets449.40
Prepaid Expense, Current AS3.95
Total Current Assets587.89
Equipment/Property/Plant Net5.26
Intangible Assets3.17
Long-term investments0.35
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent229.03
Debt Securities Current337.78
Operating Lease Right Of Use Asset1.66
Total Assets825.70
Liabilities
Accounts Payable, Current AC63.30
Accrued Liabilities, Current AC63.30
Other Liabilities, Current0.00
Taxes Payable1.03
Total Current Liabilities96.01
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE7.16
Accrued Income Taxes, Noncurrent23.13
Other liabilities, Noncurrent10.27
Contract With Customer Liability Current5.04
Operating Lease Liability Current1.62
Finance Lease Liability Noncurrent48.18
Operating Lease Liability Noncurrent2.32
Total Liabilities168.19
Stockholders' Equity
Common Stock Value1,127.50
Additional Paid In Capital Common Stock77.04
Retained Earnings / Accumulated Deficit-545.90
Accumulated Other Comprehensive Income-1.13
Other Equity-1.13
Common Stockholder's Equity657.52
Total Stockholder's Equity657.52
Liabilities & Stockholder's Equity825.70
4 historic quarters locked

Sign in to unlock the full Aurinia Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Aurinia Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001600620-26-000075

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI